
Founder & CEO of Plex Research, AI for Drug Discovery
Plex has developed a novel AI-driven analytical platform for scientists that puts the underlying scientific data front-and-center -- transparently -- for scientists to see. Plex answers complex drug discovery questions by identifying the convergence of data across far-flung, disparate raw data sources. Plex pieces together clues and hidden connections from massive amounts of data including small molecule bioactivities, gene expression profiles, genomics, proteomics, metabolomics, perturb seq data, clinical trial information, and much more. Plex works with biotech and pharma companies to address critical questions in drug discovery and development, including target ID/validation, target discovery, disease indication discovery/expansion, biomarker discovery/validation, safety assessment, and precision oncology.
novartis.com
plexresearch.com
brandeis.edu
Greater Boston
Founder & CEO
Plex Research
• www.linkedin.com/company/plex-research
Apr 2017 - Present
Cambridge, MA, USA
Associate Director, Scientific Information Systems
Novartis Institutes for BioMedical Research (NIBR)
• www.linkedin.com/company/novartis
Nov 2016 - Mar 2017
Cambridge, MA, USA
Manager, Bioinformatics (Preclinical Safety)
Novartis Institutes for BioMedical Research
• www.linkedin.com/company/novartis
Jun 2013 - Oct 2016
Cambridge, MA, USA
Research Investigator III (Developmental and Molecular Pathways)
Novartis Institutes for BioMedical Research
• www.linkedin.com/company/novartis
Sep 2011 - Jun 2013
Cambridge, MA, USA
Research Investigator II/III (Developmental and Molecular Pathways)
Novartis Institutes for Biomedical Research
• www.linkedin.com/company/novartis
Aug 2006 - Sep 2011